Loading
Latest filing published 29 Jul 2020 for TETRAPHASE PHARMACEUTICALS INC.
No signal scores available.
Christopher Watt discloses dealings in Tetraphase Pharmaceuticals Inc to SEC (Form 4). We count 4 filings; the first trade dates from 14 May 2018 and the latest from 28 July 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 29 July 2020, reports a transaction in Tetraphase Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 39 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations